<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>mtor on AndArds</title>
    <link>https://andards.com/tags/mtor/</link>
    <description>Recent content in mtor on AndArds</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 12 Apr 2026 06:48:00 +0000</lastBuildDate><atom:link href="https://andards.com/tags/mtor/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Dudley Lamming and the Protein Restriction Debate: Do We Eat Too Much Meat?</title>
      <link>https://andards.com/posts/dudley-lamming-and-the-protein-restriction-debate-do-we-eat-too-much-meat/</link>
      <pubDate>Sun, 12 Apr 2026 06:48:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/dudley-lamming-and-the-protein-restriction-debate-do-we-eat-too-much-meat/</guid>
      <description>The idea that what we eat profoundly impacts our health and longevity is hardly new. Yet, few dietary discussions spark as much intricate scientific debate as protein intake, particularly its role in aging and metabolic health. At the heart of much of this contemporary discussion is the work of researchers like Dr.</description>
    </item>
    
    <item>
      <title>Rapamycin vs. Metformin: The Great Longevity Drug Debate</title>
      <link>https://andards.com/posts/rapamycin-vs.-metformin-the-great-longevity-drug-debate/</link>
      <pubDate>Fri, 27 Mar 2026 07:33:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/rapamycin-vs.-metformin-the-great-longevity-drug-debate/</guid>
      <description>The pursuit of extended healthspan, often termed &amp;ldquo;longevity,&amp;rdquo; has led to considerable interest in pharmacological interventions. Among the compounds frequently discussed are rapamycin and metformin, two drugs with distinct mechanisms of action but overlapping potential in influencing aging pathways.</description>
    </item>
    
    <item>
      <title>David Sabatini and the Discovery of mTOR: The Master Switch of Aging</title>
      <link>https://andards.com/posts/david-sabatini-and-the-discovery-of-mtor-the-master-switch-of-aging/</link>
      <pubDate>Fri, 27 Mar 2026 06:47:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/david-sabatini-and-the-discovery-of-mtor-the-master-switch-of-aging/</guid>
      <description>The Mammalian Target of Rapamycin, or mTOR, stands as a central regulator of cell growth, metabolism, and aging. Its discovery and subsequent elucidation into a complex signaling pathway have profoundly reshaped our understanding of how organisms respond to nutrients and stress.</description>
    </item>
    
    <item>
      <title>Cycling Protein and Rapamycin: Can We Have Our Cake and Eat It Too?</title>
      <link>https://andards.com/posts/cycling-protein-and-rapamycin-can-we-have-our-cake-and-eat-it-too/</link>
      <pubDate>Fri, 13 Mar 2026 04:43:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/cycling-protein-and-rapamycin-can-we-have-our-cake-and-eat-it-too/</guid>
      <description>The quest for a longer, healthier life often involves navigating complex biological pathways. Two key players in this intricate dance are protein intake and the pharmaceutical rapamycin, both of which influence a central cellular regulator known as mTOR (mammalian Target of Rapamycin).</description>
    </item>
    
    <item>
      <title>Rapamycin for Longevity: The Current Human Trials and What We Know</title>
      <link>https://andards.com/posts/rapamycin-for-longevity-the-current-human-trials-and-what-we-know/</link>
      <pubDate>Thu, 05 Mar 2026 22:40:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/rapamycin-for-longevity-the-current-human-trials-and-what-we-know/</guid>
      <description>Rapamycin, an immunosuppressant drug, has garnered significant attention in the longevity research community due to its documented ability to extend lifespan in various organisms. This article explores the current landscape of human trials investigating rapamycin for longevity, examining the scientific basis, ongoing studies, and the cautious optimism surrounding its potential as an anti-aging drug.</description>
    </item>
    
    <item>
      <title>Dudley Lamming on Dietary Protein Restriction: Do We Eat Too Much Protein?</title>
      <link>https://andards.com/posts/dudley-lamming-on-dietary-protein-restriction-do-we-eat-too-much-protein/</link>
      <pubDate>Tue, 24 Feb 2026 05:12:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/dudley-lamming-on-dietary-protein-restriction-do-we-eat-too-much-protein/</guid>
      <description>The idea that we might be consuming too much protein, and that restricting it could offer health benefits, challenges conventional dietary advice. Dr. Dudley Lamming, a professor at the University of Wisconsin-Madison, is a prominent researcher investigating the intricate relationship between dietary protein, metabolism, and longevity.</description>
    </item>
    
    <item>
      <title>The mTOR Paradox: Why Building Muscle Might Conflict with Living Longer</title>
      <link>https://andards.com/posts/the-mtor-paradox-why-building-muscle-might-conflict-with-living-longer/</link>
      <pubDate>Thu, 19 Feb 2026 06:55:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/the-mtor-paradox-why-building-muscle-might-conflict-with-living-longer/</guid>
      <description>The pursuit of a robust physique and the desire for a long, healthy life often seem to align. Exercise, good nutrition, and strong muscles are commonly associated with vitality and longevity. However, a closer look at the cellular pathways governing growth and repair reveals a nuanced relationship, particularly concerning a central regulator known as mTOR.</description>
    </item>
    
    <item>
      <title>Brian Kennedy&#39;s Take on mTOR and Why It&#39;s the Master Switch of Aging</title>
      <link>https://andards.com/posts/brian-kennedys-take-on-mtor-and-why-its-the-master-switch-of-aging/</link>
      <pubDate>Sun, 15 Feb 2026 22:01:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/brian-kennedys-take-on-mtor-and-why-its-the-master-switch-of-aging/</guid>
      <description>The mechanistic target of rapamycin (mTOR) pathway is a central regulator of cell growth, metabolism, and survival. It has garnered significant attention in aging research, with scientists like Dr. Brian Kennedy positioning it as a fundamental &amp;ldquo;master switch&amp;rdquo; influencing the aging process.</description>
    </item>
    
    <item>
      <title>mTOR Inhibition vs. NAD&#43; Boosting: Which Pathway Matters More for Aging?</title>
      <link>https://andards.com/posts/mtor-inhibition-vs.-nad-boosting-which-pathway-matters-more-for-aging/</link>
      <pubDate>Mon, 09 Feb 2026 05:29:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/mtor-inhibition-vs.-nad-boosting-which-pathway-matters-more-for-aging/</guid>
      <description>The quest to understand and mitigate aging has led researchers down many complex biological pathways. Among the most prominent are the mechanistic target of rapamycin (mTOR) pathway and the nicotinamide adenine dinucleotide (NAD+) pathway. Both have garnered significant attention for their roles in cellular health, metabolism, and longevity.</description>
    </item>
    
    <item>
      <title>The David Sabatini mTOR Controversy: Separating the Science from the Scandal</title>
      <link>https://andards.com/posts/the-david-sabatini-mtor-controversy-separating-the-science-from-the-scandal/</link>
      <pubDate>Mon, 02 Feb 2026 03:16:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/the-david-sabatini-mtor-controversy-separating-the-science-from-the-scandal/</guid>
      <description>The name David Sabatini has become synonymous with a complex entanglement of groundbreaking scientific discovery and deeply troubling allegations. For those seeking to understand the &amp;ldquo;david sabatini mtor controversy,&amp;rdquo; it&amp;rsquo;s crucial to disentangle two distinct narratives: the significant contributions Sabatini made to our understanding of cellular biology, particularly the mTOR pathway, and the serious accusations of sexual harassment and misconduct that led to his dismissal from prominent institutions.</description>
    </item>
    
    <item>
      <title>AMPK vs. mTOR: The Seesaw of Cellular Energy and Aging</title>
      <link>https://andards.com/posts/ampk-vs.-mtor-the-seesaw-of-cellular-energy-and-aging/</link>
      <pubDate>Tue, 20 Jan 2026 05:52:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/ampk-vs.-mtor-the-seesaw-of-cellular-energy-and-aging/</guid>
      <description>The intricate machinery within our cells operates under constant surveillance, managing resources and responding to environmental cues. At the heart of this cellular management are two pivotal pathways: AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR).</description>
    </item>
    
  </channel>
</rss>
